ITGAM and B-cell chronic lymphocytic leukemia: In our model not only we can achieve a 50–60% depletion of circulating CD11b+/F4/80+ monocytes in agreement with our previous findings (16, 40), but we can also show a 2–3 fold decrease in the number of F4/80+ macrophages infiltrating the muscle upon CLL treatment.